DCGO
DocGo Inc.
Medical - Care Facilities
Market Cap$63M
5Y Perf.-93.8%
Compare Stocks
3 / 10Try these comparisons:
Stock Comparison
DCGO vs OPRX vs TALK
Revenue, margins, valuation, and 5-year total return — side by side.
OPRX
OptimizeRx Corporation
Medical - Healthcare Information Services
Market Cap$124M
5Y Perf.-78.7%
TALK
Talkspace, Inc.
Medical - Care Facilities
Market Cap$868M
5Y Perf.-52.1%
DCGO vs OPRX vs TALK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | DCGO | OPRX | TALK |
|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Healthcare Information Services | Medical - Care Facilities |
| Market Cap | $63M | $124M | $868M |
| Revenue (TTM) | $330M | $109M | $229M |
| Net Income (TTM) | $-182.40T | $5M | $8M |
| Gross Margin | 30.7% | 67.3% | 43.0% |
| Operating Margin | -55.3% | 10.7% | 1.4% |
| Forward P/E | — | 7.0x | 38.2x |
| Total Debt | $29.18T | $5M | $0.00 |
| Cash & Equiv. | $52.48T | $23M | $37M |
DCGO vs OPRX vs TALK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
DCGO
OPRX
TALK
| Stock | Dec 20 | May 26 | Return |
|---|---|---|---|
| DocGo Inc. (DCGO) | 100 | 6.2 | -93.8% |
| OptimizeRx Corporat… (OPRX) | 100 | 21.3 | -78.7% |
| Talkspace, Inc. (TALK) | 100 | 47.9 | -52.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DCGO vs OPRX vs TALK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: TALK leads in 3 of 7 categories, making it the strongest pick for capital preservation and lower volatility and recent price momentum and sentiment. OptimizeRx Corporation is the stronger pick specifically for valuation and capital efficiency and profitability and margin quality. As sector peers, any of these can serve as alternatives in the same allocation.
DCGO
DocGo Inc.
The Income Pick
DCGO is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 1 yrs, beta 2.27
- Rev growth 523K%, EPS growth -11.2%, 3Y rev CAGR 89.1%
- 523K% revenue growth vs OPRX's 18.8%
Best for: income & stability and growth exposure
OPRX
OptimizeRx Corporation
The Long-Run Compounder
OPRX is the clearest fit if your priority is long-term compounding.
- 110.5% 10Y total return vs TALK's -48.7%
- Lower P/E (7.0x vs 38.2x)
- 4.7% margin vs DCGO's -56.6%
Best for: long-term compounding
TALK
Talkspace, Inc.
The Defensive Pick
TALK has the current edge in this matchup, primarily because of its strength in sleep-well-at-night and defensive.
- Lower volatility, beta 0.86, current ratio 6.38x
- Beta 0.86, current ratio 6.38x
- Beta 0.86 vs OPRX's 2.28
Best for: sleep-well-at-night and defensive
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | DCGO | 523K% revenue growth vs OPRX's 18.8% |
| Value | OPRX | Lower P/E (7.0x vs 38.2x) |
| Quality / Margins | OPRX | 4.7% margin vs DCGO's -56.6% |
| Stability / Safety | TALK | Beta 0.86 vs OPRX's 2.28 |
| Dividends | Tie | None of these 3 stocks pay a meaningful dividend |
| Momentum (1Y) | TALK | +70.4% vs DCGO's -73.6% |
| Efficiency (ROA) | TALK | 5.9% ROA vs DCGO's -336.1%, ROIC 3.9% vs -260.4% |
DCGO vs OPRX vs TALK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
Segment breakdown not available.
Segment breakdown not available.
DCGO vs OPRX vs TALK — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLOPRXLAGGINGDCGO
DCGODocGo Inc.
1leads
TALKTalkspace, Inc.
2leads
OPRXOptimizeRx Corporation
2leads
6 Total Categories
CATEGORYLEADERvs TALKvs DCGOMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
OPRX4/5
Valuation MetricsMultiples, price ratios, and targets
DCGO4/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
OPRX4/8
Total Returns1Y, 3Y, 5Y total returns with dividends
TALK5/6
Risk & VolatilityBeta, volatility, and downside exposure
TALK2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
OPRX leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
DCGO is the larger business by revenue, generating $330M annually — 3.0x OPRX's $109M. OPRX is the more profitable business, keeping 4.7% of every revenue dollar as net income compared to DCGO's -56.6%. On growth, DCGO holds the edge at +999999.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | DCGODocGo Inc. | OPRXOptimizeRx Corpor… | TALKTalkspace, Inc. |
|---|---|---|---|
| RevenueTrailing 12 months | $330M | $109M | $229M |
| EBITDAEarnings before interest/tax | -$174.09T | $16M | $7M |
| Net IncomeAfter-tax profit | -$182.40T | $5M | $8M |
| Free Cash FlowCash after capex | $19.47T | $12M | -$2M |
| Gross MarginGross profit ÷ Revenue | +30.7% | +67.3% | +43.0% |
| Operating MarginEBIT ÷ Revenue | -55.3% | +10.7% | +1.4% |
| Net MarginNet income ÷ Revenue | -56.6% | +4.7% | +3.4% |
| FCF MarginFCF ÷ Revenue | +6.0% | +10.6% | -0.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +999999.0% | -0.2% | +29.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -41.8% | — | — |
OPRX leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
DCGO leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 24.6x trailing earnings, OPRX trades at a 81% valuation discount to TALK's 129.5x P/E. On an enterprise value basis, OPRX's 6.5x EV/EBITDA is more attractive than TALK's 137.8x.
| Metric | DCGODocGo Inc. | OPRXOptimizeRx Corpor… | TALKTalkspace, Inc. |
|---|---|---|---|
| Market CapShares × price | $63M | $124M | $868M |
| Enterprise ValueMkt cap + debt − cash | -$23.31T | $105M | $830M |
| Trailing P/EPrice ÷ TTM EPS | -0.34x | 24.56x | 129.50x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 7.04x | 38.20x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 6.55x | 137.77x |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 1.13x | 3.79x |
| Price / BookPrice ÷ Book value/share | 0.00x | 0.98x | 7.69x |
| Price / FCFMarket cap ÷ FCF | 0.00x | 6.62x | — |
DCGO leads this category, winning 4 of 6 comparable metrics.
Profitability & Efficiency
OPRX leads this category, winning 4 of 8 comparable metrics.
Profitability & Efficiency
TALK delivers a 6.9% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-6 for DCGO. OPRX carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to DCGO's 0.23x. On the Piotroski fundamental quality scale (0–9), OPRX scores 8/9 vs DCGO's 4/9, reflecting strong financial health.
| Metric | DCGODocGo Inc. | OPRXOptimizeRx Corpor… | TALKTalkspace, Inc. |
|---|---|---|---|
| ROE (TTM)Return on equity | -5.8% | +4.2% | +6.9% |
| ROA (TTM)Return on assets | -3.4% | +3.0% | +5.9% |
| ROICReturn on invested capital | -2.6% | +7.1% | +3.9% |
| ROCEReturn on capital employed | -2.4% | +7.6% | +2.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 8 | 6 |
| Debt / EquityFinancial leverage | 0.23x | 0.04x | — |
| Net DebtTotal debt minus cash | -$23.31T | -$19M | -$37M |
| Cash & Equiv.Liquid assets | $52.48T | $23M | $37M |
| Total DebtShort + long-term debt | $29.18T | $5M | $0 |
| Interest CoverageEBIT ÷ Interest expense | — | 1.26x | — |
OPRX leads this category, winning 4 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
TALK leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in TALK five years ago would be worth $5,232 today (with dividends reinvested), compared to $637 for DCGO. Over the past 12 months, TALK leads with a +70.4% total return vs DCGO's -73.6%. The 3-year compound annual growth rate (CAGR) favors TALK at 80.7% vs DCGO's -57.8% — a key indicator of consistent wealth creation.
| Metric | DCGODocGo Inc. | OPRXOptimizeRx Corpor… | TALKTalkspace, Inc. |
|---|---|---|---|
| YTD ReturnYear-to-date | -28.6% | -46.6% | +47.6% |
| 1-Year ReturnPast 12 months | -73.6% | -30.1% | +70.4% |
| 3-Year ReturnCumulative with dividends | -92.5% | -54.4% | +490.0% |
| 5-Year ReturnCumulative with dividends | -93.6% | -87.3% | -47.7% |
| 10-Year ReturnCumulative with dividends | -93.8% | +110.5% | -48.7% |
| CAGR (3Y)Annualised 3-year return | -57.8% | -23.0% | +80.7% |
TALK leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
TALK leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
TALK is the less volatile stock with a 0.86 beta — it tends to amplify market swings less than OPRX's 2.28 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TALK currently trades 99.6% from its 52-week high vs DCGO's 25.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | DCGODocGo Inc. | OPRXOptimizeRx Corpor… | TALKTalkspace, Inc. |
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.27x | 2.28x | 0.86x |
| 52-Week HighHighest price in past year | $2.45 | $22.25 | $5.20 |
| 52-Week LowLowest price in past year | $0.49 | $5.54 | $2.22 |
| % of 52W HighCurrent price vs 52-week peak | +25.9% | +29.8% | +99.6% |
| RSI (14)Momentum oscillator 0–100 | 45.1 | 46.9 | 62.7 |
| Avg Volume (50D)Average daily shares traded | 1.1M | 476K | 4.5M |
TALK leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: OPRX as "Buy", TALK as "Hold". Consensus price targets imply 156.4% upside for OPRX (target: $17) vs 1.4% for TALK (target: $5).
| Metric | DCGODocGo Inc. | OPRXOptimizeRx Corpor… | TALKTalkspace, Inc. |
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold |
| Price TargetConsensus 12-month target | — | $17.00 | $5.25 |
| # AnalystsCovering analysts | — | 15 | 10 |
| Dividend YieldAnnual dividend ÷ price | — | — | — |
| Dividend StreakConsecutive years of raises | 1 | 1 | — |
| Dividend / ShareAnnual DPS | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +2.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
OPRX leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). TALK leads in 2 (Total Returns, Risk & Volatility).
Best OverallOptimizeRx Corporation (OPRX)Leads 2 of 6 categories
Loading custom metrics...
DCGO vs OPRX vs TALK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DCGO or OPRX or TALK a better buy right now?
For growth investors, DocGo Inc.
(DCGO) is the stronger pick with 522574% revenue growth year-over-year, versus 18. 8% for OptimizeRx Corporation (OPRX). OptimizeRx Corporation (OPRX) offers the better valuation at 24. 6x trailing P/E (7. 0x forward), making it the more compelling value choice. Analysts rate OptimizeRx Corporation (OPRX) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DCGO or OPRX or TALK?
On trailing P/E, OptimizeRx Corporation (OPRX) is the cheapest at 24.
6x versus Talkspace, Inc. at 129. 5x. On forward P/E, OptimizeRx Corporation is actually cheaper at 7. 0x.
03Which is the better long-term investment — DCGO or OPRX or TALK?
Over the past 5 years, Talkspace, Inc.
(TALK) delivered a total return of -47. 7%, compared to -93. 6% for DocGo Inc. (DCGO). Over 10 years, the gap is even starker: OPRX returned +110. 5% versus DCGO's -93. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DCGO or OPRX or TALK?
By beta (market sensitivity over 5 years), Talkspace, Inc.
(TALK) is the lower-risk stock at 0. 86β versus OptimizeRx Corporation's 2. 28β — meaning OPRX is approximately 165% more volatile than TALK relative to the S&P 500. On balance sheet safety, OptimizeRx Corporation (OPRX) carries a lower debt/equity ratio of 4% versus 23% for DocGo Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DCGO or OPRX or TALK?
By revenue growth (latest reported year), DocGo Inc.
(DCGO) is pulling ahead at 522574% versus 18. 8% for OptimizeRx Corporation (OPRX). On earnings-per-share growth, the picture is similar: OptimizeRx Corporation grew EPS 124. 5% year-over-year, compared to -1122. 2% for DocGo Inc.. Over a 3-year CAGR, DCGO leads at 89. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DCGO or OPRX or TALK?
OptimizeRx Corporation (OPRX) is the more profitable company, earning 4.
7% net margin versus -56. 6% for DocGo Inc. — meaning it keeps 4. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OPRX leads at 10. 7% versus -55. 3% for DCGO. At the gross margin level — before operating expenses — OPRX leads at 67. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DCGO or OPRX or TALK more undervalued right now?
On forward earnings alone, OptimizeRx Corporation (OPRX) trades at 7.
0x forward P/E versus 38. 2x for Talkspace, Inc. — 31. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OPRX: 156. 4% to $17. 00.
08Which pays a better dividend — DCGO or OPRX or TALK?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is DCGO or OPRX or TALK better for a retirement portfolio?
For long-horizon retirement investors, Talkspace, Inc.
(TALK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 86)). DocGo Inc. (DCGO) carries a higher beta of 2. 27 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (TALK: -48. 7%, DCGO: -93. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DCGO and OPRX and TALK?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(DCGO: 99999900.0% · OPRX: -0.2%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.